- Home
- PDLB vs ADCT Comparison
PDLB vs ADCT Comparison
Compare PDLB & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- ADCT
- Stock Information
- Founded
- PDLB 1960
- ADCT 2011
- Country
- PDLB United States
- ADCT Switzerland
- Employees
- PDLB N/A
- ADCT N/A
- Industry
- PDLB
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- PDLB
- ADCT Health Care
- Exchange
- PDLB Nasdaq
- ADCT Nasdaq
- Market Cap
- PDLB 291.6M
- ADCT 224.3M
- IPO Year
- PDLB 2017
- ADCT 2020
- Fundamental
- Price
- PDLB $12.98
- ADCT $2.97
- Analyst Decision
- PDLB
- ADCT Strong Buy
- Analyst Count
- PDLB 0
- ADCT 5
- Target Price
- PDLB N/A
- ADCT $7.33
- AVG Volume (30 Days)
- PDLB 39.2K
- ADCT 827.0K
- Earning Date
- PDLB 01-28-2025
- ADCT 11-07-2024
- Dividend Yield
- PDLB N/A
- ADCT N/A
- EPS Growth
- PDLB N/A
- ADCT N/A
- EPS
- PDLB 0.37
- ADCT N/A
- Revenue
- PDLB $79,488,000.00
- ADCT $70,717,000.00
- Revenue This Year
- PDLB N/A
- ADCT $6.38
- Revenue Next Year
- PDLB $11.39
- ADCT $11.73
- P/E Ratio
- PDLB $35.20
- ADCT N/A
- Revenue Growth
- PDLB 33.32
- ADCT N/A
- 52 Week Low
- PDLB $7.89
- ADCT $0.94
- 52 Week High
- PDLB $13.24
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- PDLB 60.14
- ADCT 41.63
- Support Level
- PDLB $12.57
- ADCT $1.80
- Resistance Level
- PDLB $13.24
- ADCT $2.38
- Average True Range (ATR)
- PDLB 0.23
- ADCT 0.20
- MACD
- PDLB -0.01
- ADCT 0.00
- Stochastic Oscillator
- PDLB 63.89
- ADCT 52.27
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.